Ocular Surface Microbiome Clinical Trial
— CoFaOfficial title:
Confounding Factors in Ocular Surface Microbiome Research
Verified date | August 2022 |
Source | Universitaire Ziekenhuizen Leuven |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To elucidate confounding factors in ocular surface microbiome research and to confirm the presence of a core ocular surface microbiome and its temporal stability.
Status | Active, not recruiting |
Enrollment | 450 |
Est. completion date | January 1, 2024 |
Est. primary completion date | January 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - The subject is fluent in written and verbal Dutch - The subject is capable of giving informed consent Exclusion Criteria: - Use of glaucoma drops - Use of antibiotic drops < 1 month before sampling |
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospitals Leuven, Department of Ophthalmology | Leuven |
Lead Sponsor | Collaborator |
---|---|
Universitaire Ziekenhuizen Leuven |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Richness and evenness of distribution of the microbial flora measured as operational taxonomic units on a single moment | A conjunctival swab and extensive questionnaire will be taken to search for a core ocular surface microbiome and confounding factors | 20 minutes for samples and filling the questionnaires | |
Primary | Change in richness and evenness of distribution of the microbial flora, measured as operational taxonomic units, over time | A conjunctival swab will be taken on different points in time to investigate the temporal stability of the conjunctival microbial flora | 20 minutes for the first sample and questionnaire, 5 minutes for all other visits |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04750655 -
Antibiotic Resistance In Eye Surgeries
|
Phase 4 |